NCT06094582

Brief Summary

The use of non-medical cannabidiol (CBD) has been growing recently in France and in the world, in young but also older adults. Few data are available on the use of cannabidiol in older adults. A better knowledge of the use of cannabidiol in older adults, and of their own knowledges of the molecule, is necessary to guide and follow the CBD uptake in this population and avoid potential adverse events.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
47

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 16, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 23, 2023

Completed
3 days until next milestone

Study Start

First participant enrolled

October 26, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 26, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 26, 2023

Completed
Last Updated

December 22, 2025

Status Verified

December 1, 2025

Enrollment Period

2 months

First QC Date

October 16, 2023

Last Update Submit

December 15, 2025

Conditions

AgingFrailty

Keywords

older adultscannabidiol usefrailty

Outcome Measures

Primary Outcomes (1)

  • Prevalence of CBD use (having consumed CBD at least once)

    The patient will complete a questionnaire about CBD use

    1 day

Interventions

questionnaireOTHER

Participants will have to fulfill a short questionnaire (10 minutes) concerning their use and knowledges about CBD.

Eligibility Criteria

Age65 Years - 120 Years
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

older adults

You may qualify if:

  • admitted to the frailty clinic, in Toulouse University Hospital during the recruitment period.

You may not qualify if:

  • major cognitive disorder with Mini Mental State Examination \<20
  • being under legal supervision or guardianship.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Toulouse

Toulouse, 31059, France

Location

MeSH Terms

Conditions

Frailty

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Sandrine SOURDET, MD

    University Hospital, Toulouse

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 16, 2023

First Posted

October 23, 2023

Study Start

October 26, 2023

Primary Completion

December 26, 2023

Study Completion

December 26, 2023

Last Updated

December 22, 2025

Record last verified: 2025-12

Locations

FR(1)